|ENVISION HEALTHCARE CORP filed this Form 10-Q on 11/03/2017|
Item 1. Legal Proceedings
There have been no material changes during the nine months ended September 30, 2017 to the legal proceedings we previously described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
Item 1A. Risk Factors
There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 other than disclosed below.
Risks Related to Our Business
Risks and Uncertainties Related to our Review of Strategic Alternatives. On October 31, 2017, we announced that our Board, in consultation with management and financial and legal advisors, had unanimously decided to initiate a full review of a broad range of strategic alternatives to enhance shareholder value. There can be no assurance that this review will result in a transaction or other strategic alternative of any kind, or that if such transaction or other strategic alternative does occur, that it will successfully enhance shareholder value. In addition, the pendency of this strategic review exposes us to certain risks and uncertainties, including potential risks and uncertainties in retaining and attracting employees during the review process, the diversion of management’s time to the strategic review, and risks and uncertainties with respect to suppliers, clients and other business relationships, all of which could negatively affect our business.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information